Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02614079 · ClinicalTrials.gov registry record · NA

Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing

A NA study, sponsored by University of Toledo Health Science Campus.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT02614079 is a NA study that was terminated before completion, run by University of Toledo Health Science Campus. The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02614079, a NA study, was terminated before completion, sponsored by University of Toledo Health Science Campus.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

This study is to objectively evaluate the success of a spinal cord stimulator (SCS) trial using testing (DSSEP) to determine if the paresthesia (tingling sensation) or pain reduction achieved correlates with the degree of stimulation.

Interventions

  • DEVICE DSSEP

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2016-01-20
Est. Completion 2017-11-09
Phase NA

What the Registry Record Tells You About NCT02614079

The ClinicalTrials.gov registry entry for NCT02614079 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Toledo Health Science Campus, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which DSSEP is the first listed.

NCT02614079 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02614079 about?

NCT02614079 is a clinical study titled "Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing". This study is to objectively evaluate the success of a spinal cord stimulator (SCS) trial using testing (DSSEP) to determine if the paresthesia (tingling sensation) or pain reduction achieved correlates with the degree of stimulation.

What is the current status of trial NCT02614079?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-01-20. Estimated completion is 2017-11-09.

What interventions are being tested in trial NCT02614079?

The interventions under investigation include: DSSEP (DEVICE).

Who is sponsoring clinical trial NCT02614079?

This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.